Myeloma News

Healio is pleased to announce its partnership with CancerX, a public-private collaboration dedicated to the acceleration of innovation in cancer treatment.

Siltuximab effectively treated patients who experienced common adverse events after chimeric antigen receptor T-cell therapy, according to findings published in Blood Advances.

Healio | HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in oncology and hematology.

A new retrospective analysis has added to building evidence that suggests chimeric antigen receptor T-cell therapy does not directly cause secondary malignancies.

The FDA has approved two new biosimilars of denosumab for all indications of the reference medications Prolia and Xgeva, according to a press release from Celltrion.

As Jeff Yoshimi, PhD, wrote his book about how video games could improve scientific literacy on cancer and generate ideas that could eventually lead to treatments, he proposed this title to his mother: “Curing Disease Using Video Games.”

Psilocybin-assisted psychotherapy significantly improved a range of psychiatric symptoms among people with cancer, according to research published in Nature Mental Health.